DB16788InvestigationalGene Therapies
Adlinacogene civaparvovec is an investigational in vivo genome editing therapeutic product. It uses proprietary zinc finger nuclease (ZFN) genome editing to insert into the DNA of liver cells a copy... Developed by Sangamo Therapeutics Inc., it is being investigated for the treatment of hemophilia B.
- Code names
- SB-FIX
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Adlinacogene civaparvovec, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account